Mikkael A. Sekeres, ASH
Sylvester Comprehensive Cancer Center/LinkedIn

Mikkael A. Sekeres: ASH 2025 Guidelines for Treating Newly Diagnosed AML in Older Adults

Mikkael A. Sekeres, Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, shared a post on X about a paper he co-authored with colleagues published in Blood Advances:

“The new 2025 American Society of Hematology (ASH) Guidelines for Treating Newly Diagnosed AML in Older Adults are now online!

We provide 9 critical clinical recommendations mirroring real-time practitioner-patient conversations.”

Title: American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

Authors: Mikkael A Sekeres, Ryan J Mattison, Andrew S. Artz, Maria R Baer, Chong Chyn Chua, Roberta Demichelis-Gomez, Pamela C Egan, Luke Fletcher, Charles E. Foucar, Jacqueline S. Garcia, Linda Gilberto, Andrés Gómez-De León, Jeffrey E. Lancet, Kah Poh Loh, Luca Malcovati, Bernard Lawrence Marini, Uwe Platzbecker, Mohamed L Sorror, Sara Tinsley-Vance, John Treitz, Maria Jose Oliveros, Sara Ibrahim, Yetiani Roldan, Gordon H Guyatt, Romina Brignardello-Petersen

You can read the Full Article in Blood Advances.

Mikkael A. Sekeres: ASH 2025 Guidelines for Treating Newly Diagnosed AML in Older Adults

More posts featuring Mikkael A. Sekeres.